Dachaigh › Psoriasis › California
Sgrùdaidhean clionaigeach Psoriasis ann an California
Tha 13 sgrùdaidhean airson Psoriasis a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
- Fremont5 sgrùdaidhean
- Huntington Beach4 sgrùdaidhean
- San Diego3 sgrùdaidhean
- Los Angeles3 sgrùdaidhean
- Sacramento3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345A Study to Assess Deucravacitinib Safety in Pregnancy
- University of California San Diego, La Jolla
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT07017699A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, Fountain Valley
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07013201Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Fremont
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07362017The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
A’ fastadhÌre 4Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07487831A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- agus 1 a bharrachd
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Local Institution - 0025, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Dermatology Research Associates, Los Angeles
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50176, Fremont
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07219420The Effects of Audio-Based Therapy on Anxiety in Psoriasis
- Liao Lab at UCSF, San Francisco
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT07390487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Chula Vista
- Study Center, Fountain Valley
- Study Center, Fremont
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
- University of California, Davis - Dermatology Department, Sacramento
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT06574178Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Kinetic Clinical Research, Anaheim
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 7 Lùna 2025 · NCT06846710Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
A’ fastadhSgrùdadh amharc
Gach aois · Banairean · Air ùrachadh 28 Faoi 2025 · NCT02103361Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.